tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

scPharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright

H.C. Wainwright downgraded scPharmaceuticals (SCPH) to Neutral from Buy with a price target of $5.35, down from $18, after the company agreed to be acquired by MannKind (MNKD) for $5.35 per share in cash plus one non-tradable contingent value right per share to receive certain milestone payments of up to an aggregate of $1.00.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1